Devonian Health Group Inc.
DVHGD
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 758.30K | 930.60K | 5.18M | 6.21M | 4.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 758.30K | 930.60K | 5.18M | 6.21M | 4.48M |
| Cost of Revenue | 376.30K | 3.70K | 3.28M | 4.37M | 3.04M |
| Gross Profit | 382.00K | 926.90K | 1.90M | 1.84M | 1.45M |
| SG&A Expenses | 1.18M | 978.10K | 1.46M | 1.24M | 1.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 23.80K | 23.10K | 22.00K | 22.60K | 23.20K |
| Total Operating Expenses | 1.91M | 1.23M | 5.20M | 6.04M | 4.90M |
| Operating Income | -1.15M | -301.50K | -21.30K | 170.80K | -416.80K |
| Income Before Tax | -1.12M | -282.20K | -3.38M | 147.30K | -444.30K |
| Income Tax Expenses | -- | -9.20K | -- | 307.50K | -- |
| Earnings from Continuing Operations | -1.12M | -272.90K | -3.38M | -160.30K | -444.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.12M | -272.90K | -3.38M | -160.30K | -444.30K |
| EBIT | -1.15M | -301.50K | -21.30K | 170.80K | -416.80K |
| EBITDA | -1.12M | -276.20K | 41.40K | 233.80K | -351.50K |
| EPS Basic | -0.41 | -0.11 | -1.37 | -0.06 | -0.18 |
| Normalized Basic EPS | -0.25 | -0.07 | 0.01 | 0.04 | -0.11 |
| EPS Diluted | -0.41 | -0.11 | -1.37 | -0.06 | -0.18 |
| Normalized Diluted EPS | -0.25 | -0.07 | 0.01 | 0.04 | -0.11 |
| Average Basic Shares Outstanding | 2.76M | 2.47M | 2.47M | 2.47M | 2.47M |
| Average Diluted Shares Outstanding | 2.76M | 2.47M | 2.67M | 2.47M | 2.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |